No degradation of otilonium was found in acetonitrile.
在乙腈中未发现降解。
The present invention discloses a medical composition comprising effective amount of otilonium Br for treating irritable bowel syndrome or stomach convulsion.
本发明公开了一种治疗肠易激综合症或胃痉挛的，含治疗有效量奥替溴铵的药物组合物。
The stabilities of otilonium bromide in alcohols, water, acetonitrile and plasma were investigated by HPLC, and the degradation products were identified by LC-MS/MS, 1H-NMR and 13C-NMR.
试验中采用HPLC法考察奥替溴铵在醇、水、乙腈及血浆中的稳定性，并用LC-MS/MS、1H-NMR及13C-NMR法对其降解产物进行结构鉴定。
The stabilities of otilonium bromide in alcohols, water, acetonitrile and plasma were investigated by HPLC, and the degradation products were identified by LC-MS/MS, 1H-NMR and 13C-NMR.
试验中采用HPLC法考察奥替溴铵在醇、水、乙腈及血浆中的稳定性，并用LC-MS/MS、1H-NMR及13C-NMR法对其降解产物进行结构鉴定。
应用推荐